Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
biotech
drug discovery
2
×
life sciences
national
2
×
national blog main
national top stories
abcellera
accent therapeutics
aducanumab
alzheimer's disease
amblyotech
antibodies
asklepios biopharmaceutical
bioeurope
biogen
biomarin pharmaceutical
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
cancer
cara therapeutics
coronavirus
covid-19
deerfield management
detroit blog main
detroit top stories
drug development
eli lilly
esperion
europe blog main
europe top stories
fda
financing
gilead sciences
immunomedics
incyte
indiana blog main
What
medicines
2
×
abcellera
abcellera’s
activity
antibodies
antibody
approvals
based
bio
biogen
biologics
biotech
clamped
coronavirus
covid
delays
developing
economic
enter
fast
fda
identified
including
ipo
isn’t
leads
lot
neutralizing
new
oric’s
potentially
roundup
screening
showing
spread
testing
treat
turned
vancouver
work
Language
unset
2
×
Current search:
medicines
×
photo
×
unset
×
national
×
" drug discovery "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
AbCellera’s Coronavirus “Neutralizing” Antibody Leads Enter Screening
